INLET STRATEGIES

Lobbying for COHERUS BIOSCIENCES, INC · pharmaceutical development

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $45,000.00 income · posted Apr 14, 2025

Lobbying activity 2

Health Issues

Issues related to the federal governments procurement of Udenyca

Medicare/Medicaid

Issues related to the federal governments procurement of Udenyca

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.